ARCHIVES

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Stanford Group Working To Build ‘Superhighway’ To Synthesis Of Taxol

May 15, 1992

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014

Ethics Commission To Continue Consideration Of Compensation For Injured Research Subjects

June 20, 1980

Test May Identify Predictors For Recurrence Post-Surgery

January 28, 2011

In Brief: Potter Resigns As director Of Lombardi Cancer Center; Search Committee To Look for Successor

July 24, 1987

On More Victory For Sol Garb: FDA Approves THC

June 14, 1985